PubMed Health⌕ Search

PubMed · 2440554

Pseudoglandular hepatocellular carcinoma. A morphogenetic study.

Abstract

A histopathologic study of pseudoglandular formation was made by observing selected 39 cases of hepatocellular carcinoma (HCC). The pseudoglands were most often derived from the dilatation of bile canaliculi (28/39). The dilated canaliculi were sometimes connected and divided a cell trabecula to give a pseudopapillary appearance. A second type was concerned with tumor cell necrosis and subsequent pseudoglandular formation (6/39). A rare variant similar to papillary carcinoma was also seen in this group. Third, five cases showed microglandular formation in an scirrhous environment thereby resembling cholangiocarcinoma or metastatic adenocarcinomas. Despite these confusing features, the overall tumor histologic features, in particular the existence of a characteristic trabecular growth pattern made it possible to determine all of the cases as HCC. The importance of noticing these variable manifestations of HCC is yet emphasized in regard to differential diagnosis of hepatic tumors. The glandular elements seen in two cases of combined HCC and cholangiocarcinoma differed in that they were positive for mucin staining. In addition, the tumor cells contained mucin-positive intracytoplasmic vacuoles similar to those observed in common mucin producing adenocarcinomas.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Y Kondo, T Nakajima. 1987-09-01. Pseudoglandular hepatocellular carcinoma. A morphogenetic study.. https://doi.org/10.1002/1097-0142(19870901)60%3A5%3C1032%3A%3Aaid-cncr2820600518%3E3.0.co%3B2-k

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes.

The inflammation-associated cytokine interleukin-6 (IL-6) can contribute to tumor growth and resistance to therapy by the activation of survival mechanisms. In several human cancers, IL-6-activated survival signaling involves the signal transducers and activators of transcription (Stat) factors or protein kinase cascades. microRNAs (miRNAs) are endogenous regulators of gene expression that are altered in expression in many cancers. However, the effect of inflammatory cytokines on miRNA expression and the role of miRNA in modulating IL-6-mediated cell survival are unknown. We investigated the involvement of miRNA in malignant cholangiocytes stably transfected to overexpress IL-6, which enhances tumor growth in vivo by inhibition of apoptosis. We provide evidence that (i) miRNA expression both in vitro and in vivo is altered by overexpression of IL-6; (ii) selective miRNAs including let-7a are up-regulated and contribute to the survival effects of enforced IL-6 activity; and (iii) let-7a contributes to the constitutively increased phosphorylation of Stat-3 by a mechanism involving the neurofibromatosis 2 (NF2) gene. These findings reveal a novel mechanism by which IL-6 mediates tumor cell survival that may be therapeutically targeted and emphasize the presence of complex interrelationships between deregulated expression of miRNA and transcription factors in human cancers.

Adenoma, Bile Duct↗

Pancreatitis complicating mucin-hypersecreting common bile duct adenoma.

Villous adenomas of the bile ducts are extremely uncommon. We describe a 58-year-old man presenting with clinical signs and laboratory findings of acute pancreatitis and obstructive jaundice. Preoperative investigation demonstrated a dilated papillary orifice with mucus exiting (fish-mouth sign) and a filling defect in the distal common bile duct. He underwent a modified Whipple operation and histological examination of the surgical specimen showed villous adenoma with rich secretion of mucus.

Adenoma, Bile Duct↗

Cystic cholangiomas after transplantation of pancreatic islets into the livers of diabetic rats.

Islet transplantation is increasingly used as a therapy for human type 1 diabetes mellitus. In our study, we investigated the effect of the transplantation of a low number (n = 350) of pancreatic islets into the right liver part on the neighboring portal bile ducts. Male streptozotocin- diabetic Lewis or autoimmune-diabetic BB/Pfd rats (n = 1065) were subdivided into 11 experimental groups. A few days after low-number islet transplantation, cholangiocytes adjacent to the grafts showed an increase in proliferative activity. During the next 12-24 months, many peri-insular ductules progressed via tumor-like cystic lesions to large cystic cholangiomas, accompanied by a translocation of the insulin receptor into the cytoplasm and an increase in expression of insulin-related signaling proteins (Insulin-receptor-substrate-1, Raf-1, Mek-1). After 24 months, 53% of rats with low-number transplantation exhibited at least one cholangioma >10 mm, significantly outnumbering tumor development in the transplant-free left liver part and in any control group. No cholangiocarcinomas emerged. A graft cell origin of the tumors was excluded by Y chromosome in situ hybridization in cross-gender transplantations. Conclusively, low-number intrahepatic islet transplantation, most likely acting by permanent local hyperinsulinism, leads to prolonged cholangiocellular proliferation in streptozotocin- and in autoimmune-diabetic rats, resulting in the development of benign cystic cholangiomas.

Adenoma, Bile Duct↗